Co-Irbesan 300 mg/12,5 mg film - coated tablets
Land: Bulgarien
Sprache: Bulgarisch
Quelle: Изпълнителна агенция по лекарствата
Gebrauchsinformation
(PIL)
14-02-2018
Fachinformation
(SPC)
07-02-2018
Verfügbar ab:
Нобел Фарма ООД
ATC-Code:
C09DA4
Dosierung:
300 mg/12,5 mg film - coated tablets
Produktbesonderheiten:
CO-IRBESAN, 300 mg/12.5 mg film - coated tablets x 28 x 90
Berechtigungsdatum:
2014-04-08
